Karen Facey is a Chartered Statistician, Honorary Member of the Faculty of Public Health, and Fellow of the Royal Society of Medicine. Following a statistical career in the pharmaceutical industry and medicines regulation, Karen was founding Chief Executive of the first national Health Technology Assessment (HTA) Agency in Scotland, which established the Scottish Medicines Consortium. She now works internationally as a consultant on matters relating to HTA and patient involvement.
Karen has been on the board of a regional payer/provider of health care in Scotland for eight years. She is now a member of the Scottish Health Technologies Group, which provides national appraisal advice on non-medicine technologies. Karen chaired the Scottish Government committee that developed the funding formula for NHSScotland and currently leads the work to update the formula for acute services allocations.
Karen has been Chair of the HTAi Policy Forum and was its Scientific Secretary in 2015. She established the HTAi Interest Group on patient/citizen involvement and is on the editorial board of several journals.
In 2014 she was named as one of the top 100 practicing scientists in the UK for her work in HTA and patient wellbeing.